2025 NNECOS Corporate Membership Opportunities
https://nnecos.org/event-5860631
All membership requests must be submitted through the application form linked above. Upon approval of the application, a request letter and other documentation will be provided.
Application FAQ
The application is now open.
System note - the website has AGGRESSIVE COOKIES, so if you tried signging up for a level but were supposed to sign-up for the waitlist, you may not be able to access the waitlist "ticket". Please try an incognito browser.
2025 waitlist requests will also be accepted if a level is sold out and all lottery participants who are not able to apply will also be placed on the 2025 waitlist.
We strongly recommend securing an available corporate membership level, as the availability of a level from the waitlist cannot be guaranteed. The form includes an opportunity to request an upgrade should one become available.
Documentation of membership approval by your company, including the commitment to pay the membership dues, is required within 30 days of receipt of the necessary documentation. Non-verified requests will be released and made available to the next company on the waitlist.
(Example: Company ABC is approved for Gold Corporate membership on 9/15/24. NNECOS provides the requested documentation on 9/22/24. Company ABC is required to provide documentation of membership approval/commitment to pay membership dues no later than 10/22/24, with an explicit timeline for receipt of payment - no later than 1/31/25. Without this documentation, the spot will be made available to another company).
The board has also designated 25% of available membership opportunities for non-pharmaceutical companies (testing, equipment, software, radiation oncology, etc.). Any opportunities remaining 90 days before the annual meeting will be made available without restriction by company type. Corporate membership dues are non-refundable, paid on an annual basis, and can not be pro-rated.
Please review all levels/benefits carefully.
Codes will be sent out in small batches (3-5 companies at a time).
Companies marked in bold have completed their selection.
Code sent is highlighted in yellow.
As of 9/13/24 - all Pharma Memberships have been spoken for.
We are now converting to waitlist.
Lottery # | Company Name |
1 | Genmab |
2 | BioLineRx |
3 | Caris Life Sciences |
4 | Gilead |
5 | Regeneron Pharmaceuticals Inc |
6 | Coherus |
7 | Sanofi |
8 | Takeda Oncology |
9 | GSK |
10 | Novartis |
11 | Menarini Stemline |
12 | Syndax Pharmaceuticals |
13 | Guardant Health |
14 | Daiichi Sankyo Inc. |
15 | AstraZeneca |
16 | Agios |
17 | Servier |
18 | Foundation Medicine |
19 | Oncology Supply (a part of Cencora) |
20 | Novocure |
21 | La Roche-Posay |
22 | Beigene |
23 | Genentech |
24 | Incyte |
25 | Sumitomo Pharma |
26 | Puma Biotechnology |
27 | Legend Biotech |
28 | Amgen |
29 | Alexion Pharmaceuticals |
30 | Kite Pharma |
31 | Jazz Pharmaceuticals |
32 | Blueprint Medicines |
33 | Pfizer |
34 | Tempus |
35 | Eisai |
36 | Springworks Therapeutics |
37 | Janssen Biotech |
37 companies participated in the lottery, which was drawn via a random number generator at pickerwheel.com on 9/10/24.